Noninvasive Medical Technologies Company Description
Noninvasive Medical Technologies helps physicians provide kinder, gentler health care. The company manufactures the noninvasive hemodynamic monitors, which measure blood flow, heart rate, stroke volume, and cardiac output. IQ2 is used for patients with high blood pressure, trauma, and end stage renal disease, among other conditions. Its other device, ZOE, determines if a patient is retaining fluids or is dehydrated without drawing blood. By quickly assessing fluid status, doctors can better treat those at risk for severe or recurring dehydration such as hypertension and heart failure patients, athletes, and military personnel. The company also sells ICG sensors and electrodes used with its devices.
View the Comprehensive Company Description for Noninvasive Medical Technologies
The Company Description provides a historical perspective of Noninvasive Medical Technologies's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Noninvasive Medical Technologies's evolution in the marketplace.
